Posted in | News | Chemistry | Photonics

New Hong Kong Facility Expands Universal Display’s Footprint in Asia

Universal Display, a specialist in energy-efficient, high-performance phosphorescent OLED materials and technology, has announced that a new facility has been established in Hong Kong, which further expands the company’s presence in Asia.

An advanced chemistry laboratory will be included in the facility. The lab will support the firm’s R&D programs in OLED technologies and materials. The new facility is located at Biotech Centre 2, New Territories, Hong Kong.

Universal Display’s President and CEO, Steven V. Abramson stated that the company consistently makes investment on OLED technology advancements and continues to extend its OLED material portfolio to meet the demand of rapidly growing OLED market. He added that the new Hong Kong chemistry lab will support the development of advanced materials for OLED lighting and displays.

Universal Display Corporation Hong Kong, subsidiary of Universal Display, operates the new facility. Universal Display serves specific requirements of OLED customers by selling UniversalPHOLED materials, licensing its OLED technologies and offering technology development services.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chai, Cameron. (2019, February 09). New Hong Kong Facility Expands Universal Display’s Footprint in Asia. AZoM. Retrieved on November 23, 2024 from https://www.azom.com/news.aspx?newsID=28948.

  • MLA

    Chai, Cameron. "New Hong Kong Facility Expands Universal Display’s Footprint in Asia". AZoM. 23 November 2024. <https://www.azom.com/news.aspx?newsID=28948>.

  • Chicago

    Chai, Cameron. "New Hong Kong Facility Expands Universal Display’s Footprint in Asia". AZoM. https://www.azom.com/news.aspx?newsID=28948. (accessed November 23, 2024).

  • Harvard

    Chai, Cameron. 2019. New Hong Kong Facility Expands Universal Display’s Footprint in Asia. AZoM, viewed 23 November 2024, https://www.azom.com/news.aspx?newsID=28948.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.